معرفی
Professor Paul Lacaze is a leading researcher at the Victorian Heart Institute (VHI) at Monash University, holding a NHMRC Investigator Leadership Grant and Heart Foundation Future Leader Fellowship. He is the Chief Investigator A (CIA) of the DNA Screen national pilot study, which provides preventive population DNA screening for 10,000 healthy adults, and the A-GLIMMER project, monitoring Australia’s moratorium on genetic test use in life insurance. Lacaze leads the genomics program for the ASPREE study, the nation’s largest aging cohort trial. His research spans large-scale genomic cohort studies, ethical/legal/social implications of genomics, and preventative cardiovascular strategies.
- PhD in Genomics, University of Edinburgh
- MSc in Systems Biology, University of Edinburgh
- BSc in Science (Genomics & Biotechnology), University of Melbourne
- International Baccalaureate, Ivanhoe Grammar School
His research interests focus on public health genomics, preventive medicine, and genetic policy, with significant contributions to cardiovascular disease, ageing, dementia, and cancer. Recent trends in his work include genomic risk stratification, pharmacogenetics in older adults, and policy analysis of genetic non-discrimination laws.
- Australian Government Department of Health – 2022 MRFF Profile
- European Society of Human Genetics (2018) – Top 10 Abstracts
- Wellcome Trust Genome Campus (2016) – Human Genome Analysis
- Rhodes Award for General Excellence (1997)
- Millennium Science Outstanding Achievement (2013)
Lacaze actively advises PhD students and collaborates with institutions like the Massachusetts General Hospital, Royal Melbourne Hospital, and Garvan Institute. His grants include the NHMRC Investigator Grant and Victorian Cancer Agency funding.
He founded the Australian Genetic Non-Discrimination Working Group, influencing a parliamentary inquiry into life insurance practices, and contributes to patient groups like Rare Voices Australia and Pink Hope.
